Anti-Tuberculosis Treatment (ATT) Dosing Guidelines
The standard ATT regimen consists of isoniazid (H), rifampin (R), pyrazinamide (Z), and ethambutol (E) for the initial 2 months, followed by isoniazid and rifampin for 4 months, with specific weight-based dosing for each medication. 1, 2
First-Line Drug Dosing for Adults
Daily Dosing (Preferred)
- Isoniazid: 5 mg/kg (typically 300 mg) daily 1, 3
- Rifampin: 10 mg/kg (typically 600 mg) daily 1
- Pyrazinamide: 15-30 mg/kg daily (maximum 2g) 1, 4
- Ethambutol: 15-25 mg/kg daily 1
Intermittent Dosing (Three times weekly)
- Isoniazid: 15 mg/kg (typically 900 mg) 1, 3
- Rifampin: 10 mg/kg (typically 600 mg) 1
- Pyrazinamide: 30-40 mg/kg 1
- Ethambutol: 25-35 mg/kg 1
First-Line Drug Dosing for Children
Daily Dosing
- Isoniazid: 10-15 mg/kg daily 1, 2
- Rifampin: 10-20 mg/kg daily 1, 2
- Pyrazinamide: 35 mg/kg daily 1, 2
- Ethambutol: 20 mg/kg daily 1, 2
Treatment Duration
The standard treatment duration for drug-susceptible pulmonary tuberculosis is 6 months:
- Initial phase: 2 months of HRZE
- Continuation phase: 4 months of HR 1
Special situations requiring longer treatment:
- TB meningitis/CNS TB: 12 months (2 months HRZE + 10 months HR) 1
- Bone/joint TB in children: 12 months 1
- Military TB in children: 12 months 1
Treatment Categories
WHO categorizes TB treatment into four groups 1:
- Category I: New sputum smear-positive and other severe cases
- Category II: Retreatment cases
- Category III: New sputum smear-negative and non-severe extrapulmonary cases
- Category IV: Chronic cases
Retreatment Regimens
For previously treated patients who are more likely to have acquired drug resistance:
- Initial phase: 5 drugs (SHRZE) for 2 months, followed by 4 drugs (HRZE) for 1 month
- Continuation phase: 3 drugs (HRE) for 5 months 1
Fixed-Dose Combinations (FDCs)
FDCs are strongly recommended to improve adherence 1:
- Rifamate®: Each capsule contains rifampin (300 mg) and isoniazid (150 mg); daily dose is two capsules 1
- Rifater®: Each tablet contains rifampin (120 mg), isoniazid (50 mg), and pyrazinamide (300 mg); dosing based on weight 1
Special Considerations
Pregnancy
- All drugs except streptomycin can be used during pregnancy
- Pyridoxine (vitamin B6) 10-25 mg/day is recommended with isoniazid 1, 3
Renal Insufficiency
- Dosage adjustments needed for ethambutol and streptomycin
- Rifamate® may be used, but Rifater® should be avoided 1
Hepatic Disease
- In patients with underlying hepatic disease, single-drug formulations are preferred until safety is established 1
HIV Co-infection
- Standard regimens are effective but may require longer treatment
- Monitor for drug interactions with antiretroviral therapy 1
Directly Observed Therapy (DOT)
DOT is strongly recommended to ensure adherence and prevent drug resistance 3. This involves:
- Direct observation of medication intake by healthcare personnel
- Can be administered daily or intermittently (3 times weekly)
Monitoring
- Regular assessment of treatment response through clinical evaluation and sputum examinations
- Monitor for adverse effects, especially hepatotoxicity
- Adjust dosages with significant weight changes during treatment 2
Pitfalls to Avoid
- Inadequate initial regimen: Always include at least 4 drugs in the initial phase until susceptibility is confirmed
- Inappropriate intermittent therapy: Intermittent therapy should only be used with DOT
- Failure to adjust doses for weight: Recalculate doses with significant weight changes
- Overlooking drug interactions: Particularly important with rifampin
- Inadequate treatment duration: Shortened regimens have been shown to increase relapse rates 5
Remember that proper dosing and adherence to the full treatment course are essential to prevent treatment failure and development of drug resistance.